Cyclosporin A and doxorubicin-ifosfamide in resistant solid tumours: a phase I and an immunological study.

In order to test whether circumvention of clinical resistance can be obtained in common solid tumours by targeting different drug resistance mechanisms, a phase I clinical and immunological study was designed. The purpose of the study was to determine the dose of cyclosporin A (CsA), in combination with doxorubicin (DOX) and ifosfamide (IFX), needed to achieve steady-state whole-blood levels of 2000 ng ml-1 and the associated toxicity of this combination. Treatment consisted of CsA 5 mg kg-1 as a 2 h loading infusion, followed by a CsA 3 day continuous infusion (c.i.) (days 1-3) at doses that were escalated from 10 to 18 mg kg-1 day-1. Chemotherapy consisted of DOX 55 mg m-2 by i.v. 24 h c.i. (day 2) and IFX 2 g m-2 i.v. over 1 h on days 1 and 3. Treatments were repeated every 4 weeks. Eighteen patients with previously treated resistant solid tumours received 39 cycles. Mean steady-state CsA levels > or = 2000 ng ml-1 were reached at 5 mg kg-1 loading dose followed by a 3 day c.i. of 16 mg kg-1 day-1 or greater. Haematological toxicity was greater than expected for the same chemotherapy alone. One patient died of intracranial haemorrhage due to severe thrombopenia. Other observed toxicities were: asymptomatic hyperbilirubinaemia (46% cycles), mild nephrotoxicity (20% cycles), hypomagnesaemia (72% cycles), mild increase in body weight (100% cycles), hypertension (15% cycles) and headache (15% cycles). Overall the toxicity was acceptable and manageable. No alterations in absolute lymphocyte number, the lymphocyte subsets studied (CD3, CD4, CD8, CD19) or CD4/CD8 ratio were observed in patients receiving more than one treatment cycle, although there were significant and non-uniform variations in the values of the different lymphocyte subsets studied when pre- and post-treatment values were compared. There was also a significant increase in the CD4/CD8 ratio. Tumour regressions were observed in two patients (epidermoid carcinoma of the cervix and Ewing's sarcoma). The CsA dose recommended for phase II trials is a 5 mg kg-1 loading dose followed by a 3-day c.i. of 16 mg kg-1 day-1 simultaneously with DOX and IFX at the doses administered in this study

Giant cell granuloma of the maxilla: global management, review of literature and case report

Giant cell granuloma is a relatively rare benign entity but can be locally aggressive. Histologically characterized by intense proliferation of multinucleated giant cells and fibroblasts. Affects bone supported tissues. Definitive diagnosis is given by biopsy. Clinically manifest as a mass or nodule of reddish color and fleshy, occasionally ulcerated surface. They can range from asymptomatic to destructive lesions that grow quickly. It is a lesion to be considered in the differential diagnosis of osteolytic lesions affecting the maxilla or jaw. Its management passed from conservative treatment with intralesional infiltration of corticosteroids, calcitonin or interferon, to the surgical resection and reconstruction, for example with microvascular free flaps. Keywords: giant cell granuloma, intralesional injection, microvascular free flap, fibula

Electrical conductivity measurements of films

Póster presentado en la 12th European Conference on Thermoelectrics (ECT2014), celebrada en Madrid del 24 al 26 de septiembre de 2014.The characterization of the electrical conductivity of thin films is mandatory in all materials but particularly in thermoelectricity, its measurement is crucial in order to be able to determine the power factor and the figure of merit. A technique that could be used to carry out electrical measurements on thin films is the four probe technique. However, the spreading of the current due to the electrical field or the influence of the electrical contact resistances complicate the determination and analysis of the electrical conductivity of the film. In order to overcome these problems, we carried out a mesa attack on Bi2Te3 films grown by electrodeposition technique, which are hold on a Si substrate with a gold layer of 150nm. The goal is fabricating pillars whose later film resistivity analysis could approach to the 1D electrical model, which cannot be taken into account when dealing with a big film area. For that purpose, a lithography process was done on films with different thicknesses, which consist of a pattern of disks with different diameters ranging between 120µm and 60µm diameter. After the lithography, we evaporated 100nm of gold on top of the disks that would act as the top electrode. Then, we removed the photoresist and we performed a mesa attack with diluted nitric acid (1:2.5). As a result, we obtained pillars as the ones showed in Figure 1. On these pillars, I-V curves with the four probe technique were taken and the resistances of the pillars were determined. Representing the resistance of the pillars versus the inverse of the area of the pillar, the total resistivity of the films, which includes the contact resistances between the electrodes and the pillar, is obtained. Finally, to determine the electrical contact resistance and obtain the pure electrical resistivity of the film, these measurements were performed on different pillar thicknesses. The experimental results have been double-checked with COMSOL simulations of the four probe experiments carried out here, observing a good agreement between them.Peer Reviewe

Implementing a privacy-enhanced attribute-based credential system for online social networks with co-ownership management

Online social network (OSN) users are exhibiting an increased privacy-protective behaviour especially since multimedia sharing has emerged as a popular activity over most OSN sites. Popular OSN applications could reveal much of the users' personal information or let it easily derived, hence favouring different types of misbehaviour. In this article the authors deal with these privacy concerns by applying fine-grained access control and co-ownership management over the shared data. This proposal defines access policy as any linear boolean formula that is collectively determined by all users being exposed in that data collection namely the co-owners. All co-owners are empowered to take part in the process of data sharing by expressing (secretly) their privacy preferences and, as a result, jointly agreeing on the access policy. Access policies are built upon the concept of secret sharing systems. A number of predicates such as gender, affiliation or postal code can define a particular privacy setting. User attributes are then used as predicate values. In addition, by the deployment of privacy-enhanced attribute-based credential technologies, users satisfying the access policy will gain access without disclosing their real identities. The authors have implemented this system as a Facebook application demonstrating its viability, and procuring reasonable performance costs

Functional reconstruction after subtotal glossectomy in the surgical treatment of an uncommon and aggressive neoplasm in this location: primary malignant melanoma in the base of the tongue

Primary malignant melanoma of the oral cavity is a rare neoplasm, especially on the tongue. We report a case of mucosal melanoma at the base of the tongue, an extremely rare location (only about 30 cases have been reported in literature). The extension study doesn't revealed distant metastatic lesions. The patient was treated by subtotal glossectomy and bilateral functional neck dissection. Tongue is one of the most difficult structures to reconstruct, because of their central role in phonation, swallowing and airway protection. The defect was reconstructed with anterolateral thigh free flap. Surgical treatment was supplemented with adjuvant immunotherapy. The post-operative period was uneventful. At present, 24 months after surgery, patient is asymptomatic, there isn't evidence of recurrence of melanoma and he hasn't any difficulty in swallowing or phonation

Costochondral graft with green-stick fracture used in reconstruction of the mandibular condyle : experience in 13 clinical cases

Since its publication in 1920 by Gillies, costochondral grafts have been used by surgeons to replace an injured mandibular condyle and to reconstruct the temporomandibular joint. This procedure is currently applied in cases of congenital dysplasia, developmental defects, temporomandibular ankylosis, neoplastic disease, osteoarthritis and post-traumatic dysfunction. Over the years, various procedures for the reconstruction with this type of graft have been described. In 1989, Mosby and Hiatt described a technique for setting the graft securely, reducing the space between the graft and the mandibular area. In 1998, Monje and Martín-Granizo developed a variation of this method, enabling a precise adaptation of the costochondral graft to the remaining mandibular ramus. The aim of this study is to evaluate the functional and anatomic results of the costochondral graft treatment by green-stick fracture for reconstruction of the TMJ in the 10 years following the description of this technique. We carry out a retrospective study of thirteen cases of temporomandibular pathology (tumors, ankylosis and hypoplasia) treated during a period of ten years from 1998 to 2008. In all these cases, the technique described by Monje and MartínGranizo was used: removal of the sixth rib, fixation to a titanium mini-plate using screws, making an internal corticotomy in order to obtain a green-stick fracture of the outer cortex, providing adequate adaptation of the graft to the mandibular ramus. The graft was then set in place, attaching it with titanium screws. This technique was successful in achieving optimal ossification, a good interincisal opening and satisfactory cosmetic results. In conclusion, according to our experience, the green-stick fracture for the adaptation of costochondral grafts to the remaining mandibular ramus has presented outstanding results in the surgical treatment of temporomandibular pathology

SoNeUCON_{ABC}Pro: an access control model for social networks with translucent user provenance

Proceedings of: SecureComm 2017 International Workshops, ATCS and SePrIoT, Niagara Falls, ON, Canada, October 22–25, 2017Web-Based Social Networks (WBSNs) are used by millions of people worldwide. While WBSNs provide many benefits, privacy preservation is a concern. The management of access control can help to assure data is accessed by authorized users. However, it is critical to provide sufficient flexibility so that a rich set of conditions may be imposed by users. In this paper we coin the term user provenance to refer to tracing users actions to supplement the authorisation decision when users request access. For example restricting access to a particular photograph to those which have “liked” the owners profile. However, such a tracing of actions has the potential to impact the privacy of users requesting access. To mitigate this potential privacy loss the concept of translucency is applied. This paper extends SoNeUCONABC model and presents SoNeUCONABCPro, an access control model which includes translucent user provenance. Entities and access control policies along with their enforcement procedure are formally defined. The evaluation demonstrates that the system satisfies the imposed goals and supports the feasibility of this model in different scenarios.This work was supported by the MINECO grants TIN2013-46469-R (SPINY: Security and Privacy in the Internet of You) and TIN2016-79095-C2-2-R (SMOG-DEV); by the CAM grant S2013/ICE-3095 (CIBERDINE: Cybersecurity, Data, and Risks); and by the Programa de Ayudas para la Movilidad of Carlos III University of Madrid, Spain (J. M. de Fuentes and L. Gonzalez-Manzano grants)

Relationship between the Sensory-Determined Astringency and the Flavanolic Composition of Red Wines

[EN] The relationship between the proanthocyanidin profile and the perceived astringency was assessed in 13 commercial Tempranillo red wines. The concentration and compositional information were obtained by liquid chromatography with diode array detection coupled to electrospray ionization mass spectrometry after acid-catalyzed depolymerization of wine proanthocyanidins in the presence of excess phloroglucinol. Statistical analysis of the results showed significant correlations between sensory and chemical determinations. Astringency was more affected by the subunit composition than by the total concentration or the average degree of polymerization of wine proanthocyanidins. Higher proportions of epicatechin (EC) subunits in extension positions and gallocatechin (GC) subunits in terminal positions were shown to increase astringency. On the contrary, the amount of epigallocatechin (EGC) in both extension and terminal positions was negatively correlated with the perceived astringency

Estimation of Admission D-dimer Cut-off Value to Predict Venous Thrombotic Events in Hospitalized COVID-19 Patients: Analysis of the SEMI-COVID-19 Registry

Background: Venous thrombotic events (VTE) are frequent in COVID-19, and elevated plasma D-dimer (pDd) and dyspnea are common in both entities. Objective: To determine the admission pDd cut-off value associated with in-hospital VTE in patients with COVID-19. Methods: Multicenter, retrospective study analyzing the at-admission pDd cut-off value to predict VTE and anticoagulation intensity along hospitalization due to COVID-19. Results: Among 9386 patients, 2.2% had VTE: 1.6% pulmonary embolism (PE), 0.4% deep vein thrombosis (DVT), and 0.2% both. Those with VTE had a higher prevalence of tachypnea (42.9% vs. 31.1%; p = 0.0005), basal O2 saturation <93% (45.4% vs. 33.1%; p = 0.0003), higher at admission pDd (median [IQR]: 1.4 [0.6–5.5] vs. 0.6 [0.4–1.2] µg/ml; p < 0.0001) and platelet count (median [IQR]: 208 [158–289] vs. 189 [148–245] platelets × 109/L; p = 0.0013). A pDd cut-off of 1.1 µg/ml showed specificity 72%, sensitivity 49%, positive predictive value (PPV) 4%, and negative predictive value (NPV) 99% for in-hospital VTE. A cut-off value of 4.7 µg/ml showed specificity of 95%, sensitivity of 27%, PPV of 9%, and NPV of 98%. Overall mortality was proportional to pDd value, with the lowest incidence for each pDd category depending on anticoagulation intensity: 26.3% for those with pDd >1.0 µg/ml treated with prophylactic dose (p < 0.0001), 28.8% for pDd for patients with pDd >2.0 µg/ml treated with intermediate dose (p = 0.0001), and 31.3% for those with pDd >3.0 µg/ml and full anticoagulation (p = 0.0183). Conclusions: In hospitalized patients with COVID-19, a pDd value greater than 3.0 µg/ml can be considered to screen VTE and to consider full-dose anticoagulation. © 2021, Society of General Internal Medicine